ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

アロセトロン

Alosetron

HCID 2099
反応を作成
印刷

データを補完しています。しばらくしてからページを更新すると最新の内容を表示できます

基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
122852-42-0
標準SMILES
Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O
InChIKey
JSWZEAMFRNKZNL-UHFFFAOYSA-N
分子式
C17H18N4O
平均分子量
294.35 g/mol
単同位体質量
294.14806121

概要

Alosetron is a pyrido[4,3-b]indole compound having a 5-methyl-1H-imidazol-4-ylmethyl group at the 2-position. It has a role as a serotonergic antagonist, an antiemetic and a gastrointestinal drug. It is a member of imidazoles and a pyridoindole.

名称と識別子

優先名称
Alosetron
IUPAC
5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-3,4-dihydropyrido[4,3-b]indol-1-one
現地名
アロセトロン
英語名
Alosetron
分子式
C17H18N4O
分子量
294.35

名称と別名

alosetron122852-42-0alosetron monohydrochlorideGR68755GR 68755alosetronum5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-3,4-dihydropyrido[4,3-b]indol-1-oneA03AE01CHEBI:25334213Z9HTH1152,3,4,5-Tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-1H-pyrido(4,3-b)indol-1-one1H-Pyrido(4,3-b)indol-1-one, 2,3,4,5-tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-
名称をさらに表示
アロセトロン5-メチル-2-[(5-メチル-1H-イミダゾール-4-イル)メチル]-1H,2H,3H,4H,5H-ピリド[4,3-b]インドール-1-オン3,4-ジヒドロ-5-メチル-2-[(5-メチル-1H-イミダゾール-4-イル)メチル]-5H-ピリド[4,3-b]インドール-1(2H)-オン2,3,4,5-テトラヒドロ-5-メチル-2-[(5-メチル-1H-イミダゾール-4-イル)メチル]-1H-ピリド[4,3-b]インドール-1-オン2-[(5-メチル-1H-イミダゾール-4-イル)メチル]-5-メチル-3,4-ジヒドロ-γ-カルボリン-1(2H)-オンaloosetron.GR-68755XGR-68755ALOSETRON USP/EP/BPAlosetron (GR-68755XGR 68755XGR-687559-methyl-3-(5-methyl-3H-Imidazol-4-ylmethyl)- 1,2,3,9-Tetrahydro-9-methyl-3-(5-methyl-3H-Imidazol-4-ylmethyl)-1,2,3,9-Tetrahydro-Carbazol-4-One Hydrochloride5-Methyl-2-[(4-methyl-1H-imidazol-5-yl)methyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-one
DTXSID60442785-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-1H,2H,3H,4H,5H-pyrido[4,3-b]indol-1-one2,3,4,5-Tetrahydro-5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-1H-pyrido[4,3-b]indol-1-one5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-1H,2H,3H,4H,5H-pyrido(4,3-b)indol-1-one5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-3,4-dihydropyrido(4,3-b)indol-1-oneRefChem:58090DTXCID4024278Lotronex

物性

構造計算による物性補完中

XLogP
1.6
極性表面積
53.9 Ų
水素結合供与体数
1
水素結合受容体数
2
回転可能結合数
2
重原子数
22
形式電荷
0
複雑度
442

実験および物理化学的性質

DrugsPharmaceuticals -> Listed in ZINC15
LogP2
Solubility4.38e-01 g/L
Human DrugsBreast Feeding; Lactation; Gastrointestinal Agents; Serotonin Antagonists;
Physical DescriptionSolid

物理化学的性質

融点
238 · 238-240 °C
沸点
648.1 · 648.1±55.0 °C(Predicted)
比重(密度)
1.34 · 1.34±0.1 g/cm3(Predicted)
貯蔵温度
-20 °C · Store at -20°C
溶解性
DMSO
外見
Powder
酸解離定数(Pka)
14.1 · 14.10±0.10(Predicted)

化学的性質

化学的特性crystalline powder

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

毒性情報

Adverse Effects · 1 件

The most common adverse effect associated with alosetron administration is constipation. A randomized, double-blind, placebo-controlled study assessed the efficacy and safety of alosetron 0.5 mg and 1 mg in women with severe IBS-D. The study data revealed that constipation occurred in patients receiving 0.5 mg (9%), 1 mg once daily (16%), and 1 mg twice daily (19%).

Toxicity SummarySigns and Symptoms of Overdose
Drug Induced Liver Injury · 5 件

Drug-Induced Liver Injury Severity and Toxicity (DILIst)

alosetron

DILI Positive

Oral

DOI:10.1016/j.drudis.2019.09.022

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

安全データ

risk_code
36/37/38
hazard_code
Xi
safety_code
26-36

化学と産業

薬理情報

ATC Code · 2 件

A - Alimentary tract and metabolism

QA - Alimentary tract and metabolism

Protein Binding82%
Pharmacodynamics · 1 件

Alosetron is a potent and selective antagonist of the serotonin 5-HT<sub>3</sub> receptor type. Activation of these receptors and the resulting neuronal depolarization affects the regulation of visceral pain, colonic transit, and GI secretions processes that are related to IBS. By blocking these receptors, alosetron is able to effectively control IBS.

Mechanism of Action · 1 件

Alosetron is a potent and selective 5-HT<sub>3</sub> receptor antagonist. 5-HT<sub>3</sub> receptors are nonselective cation channels that are extensively distributed on enteric neurons in the human gastrointestinal tract, as well as other peripheral and central locations. Activation of these channels and the resulting neuronal depolarization affect the regulation of visceral pain, colonic transit and gastrointestinal secretions, processes that relate to the pathophysiology of irritable bowel syndrome (IBS). 5-HT<sub>3</sub> receptor antagonists such as alosetron inhibit activation of non-selective cation channels which results in the modulation of serotonin-sensitive GI motor and sensory processes.

Biological Half-Life1.5 hours
Metabolism/Metabolites · 2 件

Hepatic, via microsomal cytochrome P450 (CYP)

Alosetron has known human metabolites that include 6-hydroxy-5-methyl-2-[(5-methyl-2-oxo-1,3-dihydroimidazol-4-yl)methyl]-3,4-dihydropyrido[4,3-b]indol-1-one and 6-Hydroxy-5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-3,4-dihydropyrido[4,3-b]indol-1-one.

FDA Pharmacological Classification · 6 件

13Z9HTH115

ALOSETRON

Mechanisms of Action [MoA] - Serotonin 3 Receptor Antagonists

Established Pharmacologic Class [EPC] - Serotonin-3 Receptor Antagonist

Alosetron is a Serotonin-3 Receptor Antagonist. The mechanism of action of alosetron is as a Serotonin 3 Receptor Antagonist.

関連反応

21 件
反応記録を作成
HRID 125219 の反応式
HRID 125219生成物として
HRID 297715 の反応式
HRID 297715反応物として
HRID 484098 の反応式
HRID 484098生成物として
HRID 484099 の反応式
HRID 484099反応物として
HRID 937523 の反応式
HRID 937523生成物として
HRID 1197489 の反応式
HRID 1197489反応物として
HRID 1217666 の反応式
HRID 1217666生成物として
HRID 1588272 の反応式
HRID 1588272生成物として
前へ1 / 3 ページ

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート

データベース識別子

CAS
122852-42-0
PubChem CID
2099
DTXSID
DTXSID6044278
ChEMBL
CHEMBL1110
ChEBI
CHEBI:253342
UNII
13Z9HTH115
Nikkaji
J532.750D

ALOSETRON

MeSH Pharmacological Classification · 2 件

Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion.

Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS.

Absorption, Distribution and Excretion · 4 件

50-60 %

Renal elimination of unchanged alosetron accounts for only 6% of the dose. Alosetron is extensively metabolized in humans.

65 to 95 L

600 mL/min

Cellular LocationsMembrane

応用分野

使用Anti-emetic.

上流・下流製品情報

上流原料

4-ヒドロキシメチル-1H-トリチルイミダゾール水素化ナトリウムポリりん酸塩化スルフィニルマレイン酸塩酸ヒドロキシルアミン2-メトキシエタノール

補足説明

定義ChEBI: A pyrido[4,3-b]indole compound having a 5-methyl-1H-imidazol-4-ylmethyl group at the 2-position.